top of page
biognosys

a paradigm shifting proteomics platform

biognosys

redalpine

precise biomarker discovery for better diagnosis

biognosys is a proteomics company specializing in mass spectrometry-based solutions for precise protein quantification and biomarker discovery. its paradigm shifting platform enables the comprehensive analysis of complex biological samples, aiding researchers in understanding cellular processes and diseases. biognosys' patented tools accelerate the drug development process, providing better diagnosis, and allowing patient specific treatment schemes.

related stories

Jan 12, 2016

Another successful exit for Redalpine

bottom of page